Treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor drugs: progress from mechanisms to clinical applications

被引:1
|
作者
Cheng, Shizhou [1 ]
Zhang, Shu [1 ]
Huang, Mingyan [1 ]
Liu, Yuxuan [1 ]
Zou, Xunyu [1 ]
Chen, Xiaoming [1 ]
Zhang, Zuhai [1 ]
机构
[1] Yangtze Univ, Dept Ophthalmol, Affiliated Hosp 1, Jingzhou, Peoples R China
关键词
neovascular age-related macular degeneration; vascular endothelial growth factor; treatment; mechanism; clinical application; INTRAVITREAL AFLIBERCEPT INJECTION; RANIBIZUMAB; THERAPY; VEGF; ANGIOGENESIS; OUTCOMES; PHARMACOKINETICS; CLASSIFICATION; DISCOVERY; HISTORY;
D O I
10.3389/fmed.2024.1411278
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neovascular age-related macular degeneration (nARMD) is an important cause of visual impairment and blindness in the elderly, with choroidal neovascularization in the macula as the main pathological feature. The onset of nARMD is closely related to factors including age, oxidative stress, and lipid metabolism. Vascular endothelial growth factor (VEGF) is an important factor contributing to nARMD as well as choroidal neovascularization and retinal leakage formation. At present, anti-VEGF therapy is the only treatment that improves vision and halts disease progression in most patients, making anti-VEGF drugs a landmark development for nARMD treatment. Although intravitreal injection of anti-VEGF drugs has become the first-line treatment for nARMD, this treatment has many shortcomings including repeated injections, poor or no response in some patients, and complications such as retinal fibrosis. As a result, several new anti-VEGF drugs are being developed. This review provides a discussion of these new anti-VEGF drugs for the treatment of nARMD.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
    Solomon, Sharon D.
    Lindsley, Kristina
    Vedula, Satyanarayana S.
    Krzystolik, Magdalena G.
    Hawkins, Barbara S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (03):
  • [2] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
    Solomon, Sharon D.
    Lindsley, Kristina
    Vedula, Satyanarayana S.
    Krzystolik, Magdalena G.
    Hawkins, Barbara S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [3] Disparities in access to anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
    Finger, Robert P.
    Xie, Jing
    Fotis, Kathy
    Parikh, Sumit
    Cummins, Rob
    Mitchell, Paul
    Guymer, Robyn H.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 (02): : 143 - 151
  • [4] Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration
    Finger, Robert P.
    Puth, Marie-Therese
    Schmid, Matthias
    Barthelmes, Daniel
    Guymer, Robyn H.
    Gillies, Mark
    JAMA OPHTHALMOLOGY, 2020, 138 (12) : 1234 - 1240
  • [5] Effects of suspension of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration in clinical setting
    Matsubara, Hisashi
    Matsui, Yoshitsugu
    Miyata, Ryohei
    Ichio, Atsushi
    Chujo, Shinichiro
    Enomoto, Hiroko
    Sugimoto, Masahiko
    Kondo, Mineo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (06) : 1867 - 1876
  • [6] Effects of suspension of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration in clinical setting
    Hisashi Matsubara
    Yoshitsugu Matsui
    Ryohei Miyata
    Atsushi Ichio
    Shinichiro Chujo
    Hiroko Enomoto
    Masahiko Sugimoto
    Mineo Kondo
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 1867 - 1876
  • [7] Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration (Review)
    Sunaga, Tomiko
    Maeda, Masayuki
    Saulle, Rosella
    Ng, Sueko M.
    Sato, Miki Takenaka
    Hasegawa, Takeshi
    Mason, Andrew N.
    Noma, Hisashi
    Ota, Erika
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (06):
  • [8] Patterns of anti-vascular endothelial growth factor discontinuation in neovascular age-related macular degeneration
    Basilious, Amy
    Smuck, Bobbi
    Duncan, Julie
    Malvankar-Mehta, Monali S.
    Juncal, Verena R.
    Hooper, Phil
    Sheidow, Tom G.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2024, 59 (02): : e161 - e169
  • [9] Radiotherapy for anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration
    Ying, Gui-shuang
    Vanderbeek, Brian L.
    LANCET, 2024, 404 (10447): : 4 - 5
  • [10] Durability of anti-vascular endothelial growth factor agents in neovascular age-related macular degeneration
    Sivaprasad, Sobha
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 49 (06): : 540 - 541